Bevacizumab as maintenance therapy in mCRC: Interpreting results of the MOMA trial

by Marmorino, Federica, Falcone, Alfredo, Cremolini, Chiara
Published in Oncotarget (2019)

Immune Checkpoint Inhibitors in pMMR Metastatic Colorectal Cancer: A Tough Challenge

by Marmorino, Federica, Boccaccino, Alessandra, Germani, Marco Maria, Falcone, Alfredo, Cremolini, Chiara
Published in Cancers (Basel) (2020)

Surrogate Endpoints in Second-Line Trials of Targeted Agents in Metastatic Colorectal Cancer: A Literature-Based Systematic Review and Meta-Analysis

by Cremolini, Chiara, Antoniotti, Carlotta, Pietrantonio, Filippo, Berenato, Rosa, Tampellini, Marco, Baratelli, Chiara, Salvatore, Lisa, Marmorino, Federica, Borelli, Beatrice, Nichetti, Federico, Bironzo, Paolo, Sonetto, Cristina, Bartolomeo, Maria Di, de Braud, Filippo, Loupakis, Fotios, Falcone, Alfredo, Maio, Massimo Di
Published in Cancer Res Treat (2017)

Serum LDH predicts benefit from bevacizumab beyond progression in metastatic colorectal cancer

by Marmorino, Federica, Salvatore, Lisa, Barbara, Cecilia, Allegrini, Giacomo, Antonuzzo, Lorenzo, Masi, Gianluca, Loupakis, Fotios, Borelli, Beatrice, Chiara, Silvana, Banzi, Maria Chiara, Miraglio, Emanuela, Amoroso, Domenico, Dargenio, Francesco, Bonetti, Andrea, Martignetti, Angelo, Paris, Myriam, Tomcikova, Daniela, Boni, Luca, Falcone, Alfredo, Cremolini, Chiara
Published in Br J Cancer (2017)

Vinorelbine in BRAF V600E mutated metastatic colorectal cancer: a prospective multicentre phase II clinical study

by Cremolini, Chiara, Pietrantonio, Filippo, Tomasello, Gianluca, Dadduzio, Vincenzo, Moretto, Roberto, Morano, Federica, Schirripa, Marta, Antoniotti, Carlotta, Fucà, Giovanni, Bergamo, Francesca, Rossini, Daniele, Nichetti, Federico, Ziampiri, Stamatia, Ghidini, Michele, Marmorino, Federica, Prisciandaro, Michele, Falcone, Alfredo, De Braud, Filippo, Loupakis, Fotios, Lonardi, Sara
Published in ESMO Open (2017)

Location of Primary Tumor and Benefit From Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer

by Moretto, Roberto, Cremolini, Chiara, Rossini, Daniele, Pietrantonio, Filippo, Battaglin, Francesca, Mennitto, Alessia, Bergamo, Francesca, Loupakis, Fotios, Marmorino, Federica, Berenato, Rosa, Marsico, Valentina Angela, Caporale, Marta, Antoniotti, Carlotta, Masi, Gianluca, Salvatore, Lisa, Borelli, Beatrice, Fontanini, Gabriella, Lonardi, Sara, De Braud, Filippo, Falcone, Alfredo
Published in Oncologist (2016)

Single-Agent Panitumumab in Frail Elderly Patients With Advanced RAS and BRAF Wild-Type Colorectal Cancer: Challenging Drug Label to Light Up New Hope

by Pietrantonio, Filippo, Cremolini, Chiara, Aprile, Giuseppe, Lonardi, Sara, Orlandi, Armando, Mennitto, Alessia, Berenato, Rosa, Antoniotti, Carlotta, Casagrande, Mariaelena, Marsico, Valentina, Marmorino, Federica, Cardellino, Giovanni Gerardo, Bergamo, Francesca, Tomasello, Gianluca, Formica, Vincenzo, Longarini, Raffaella, Giommoni, Elisa, Caporale, Marta, Di Bartolomeo, Maria, Loupakis, Fotios, de Braud, Filippo
Published in Oncologist (2015)

TRIBE-2: a phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group

by Cremolini, Chiara, Marmorino, Federica, Loupakis, Fotios, Masi, Gianluca, Antoniotti, Carlotta, Salvatore, Lisa, Schirripa, Marta, Boni, Luca, Zagonel, Vittorina, Lonardi, Sara, Aprile, Giuseppe, Tamburini, Emiliano, Ricci, Vincenzo, Ronzoni, Monica, Pietrantonio, Filippo, Valsuani, Chiara, Tomasello, Gianluca, Passardi, Alessandro, Allegrini, Giacomo, Di Donato, Samantha, Santini, Daniele, Falcone, Alfredo
Published in BMC Cancer (2017)

AtezoTRIBE: a randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorec...

by Antoniotti, Carlotta, Borelli, Beatrice, Rossini, Daniele, Pietrantonio, Filippo, Morano, Federica, Salvatore, Lisa, Lonardi, Sara, Marmorino, Federica, Tamberi, Stefano, Corallo, Salvatore, Tortora, Giampaolo, Bergamo, Francesca, Brunella, Di Stefano, Boccaccino, Alessandra, Grassi, Elisa, Racca, Patrizia, Tamburini, Emiliano, Aprile, Giuseppe, Moretto, Roberto, Boni, Luca, Falcone, Alfredo, Cremolini, Chiara
Published in BMC Cancer (2020)

FOLFOXIRI‐Bevacizumab or FOLFOX‐Panitumumab in Patients with Left‐Sided RAS/BRAF Wild‐Type Metastatic Colorectal Cancer: A Propensity Score‐Based Analysis

by Pietrantonio, Filippo, Fucà, Giovanni, Rossini, Daniele, Schmoll, Hans‐Joachim, Bendell, Johanna C., Morano, Federica, Antoniotti, Carlotta, Corallo, Salvatore, Borelli, Beatrice, Raimondi, Alessandra, Marmorino, Federica, Niger, Monica, Boccaccino, Alessandra, Masi, Gianluca, Lonardi, Sara, Boni, Luca, de Braud, Filippo, Di Bartolomeo, Maria, Falcone, Alfredo, Cremolini, Chiara
Published in Oncologist (2021)

Differential histopathologic parameters in colorectal cancer liver metastases resected after triplets plus bevacizumab or cetuximab: a pooled analysis of five prospective trials

by Cremolini, Chiara, Milione, Massimo, Marmorino, Federica, Morano, Federica, Zucchelli, Gemma, Mennitto, Alessia, Prisciandaro, Michele, Lonardi, Sara, Pellegrinelli, Alessio, Rossini, Daniele, Bergamo, Francesca, Aprile, Giuseppe, Urbani, Lucio, Morelli, Luca, Schirripa, Marta, Cardellino, Giovanni Gerardo, Fassan, Matteo, Fontanini, Gabriella, de Braud, Filippo, Mazzaferro, Vincenzo, Falcone, Alfredo, Pietrantonio, Filippo
Published in Br J Cancer (2018)

DPYD and UGT1A1 genotyping to predict adverse events during first-line FOLFIRI or FOLFOXIRI plus bevacizumab in metastatic colorectal cancer

by Cremolini, Chiara, Del Re, Marzia, Antoniotti, Carlotta, Lonardi, Sara, Bergamo, Francesca, Loupakis, Fotios, Borelli, Beatrice, Marmorino, Federica, Citi, Valentina, Cortesi, Enrico, Moretto, Roberto, Ronzoni, Monica, Tomasello, Gianluca, Zaniboni, Alberto, Racca, Patrizia, Buonadonna, Angela, Allegrini, Giacomo, Ricci, Vincenzo, Di Donato, Samantha, Zagonel, Vittorina, Boni, Luca, Falcone, Alfredo, Danesi, Romano
Published in Oncotarget (2017)

The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials

by Fucà, Giovanni, Guarini, Vincenzo, Antoniotti, Carlotta, Morano, Federica, Moretto, Roberto, Corallo, Salvatore, Marmorino, Federica, Lonardi, Sara, Rimassa, Lorenza, Sartore-Bianchi, Andrea, Borelli, Beatrice, Tampellini, Marco, Bustreo, Sara, Claravezza, Matteo, Boccaccino, Alessandra, Murialdo, Roberto, Zaniboni, Alberto, Tomasello, Gianluca, Loupakis, Fotios, Adamo, Vincenzo, Tonini, Giuseppe, Cortesi, Enrico, de Braud, Filippo, Cremolini, Chiara, Pietrantonio, Filippo
Published in Br J Cancer (2020)

Activity and Safety of Cetuximab Plus Modified FOLFOXIRI Followed by Maintenance With Cetuximab or Bevacizumab for RAS and BRAF Wild-type Metastatic Colorectal Cancer: A Randomized...

by Cremolini, Chiara, Antoniotti, Carlotta, Lonardi, Sara, Aprile, Giuseppe, Bergamo, Francesca, Masi, Gianluca, Grande, Roberta, Tonini, Giuseppe, Mescoli, Claudia, Cardellino, Giovanni Gerardo, Coltelli, Luigi, Salvatore, Lisa, Corsi, Domenico Cristiano, Lupi, Cristiana, Gemma, Donatello, Ronzoni, Monica, Dell’Aquila, Emanuela, Marmorino, Federica, Di Fabio, Francesca, Mancini, Maria Laura, Marcucci, Lorenzo, Fontanini, Gabriella, Zagonel, Vittorina, Boni, Luca, Falcone, Alfredo
Published in JAMA Oncol (2018)

TRIPLETE: a randomised phase III study of modified FOLFOXIRI plus panitumumab versus mFOLFOX6 plus panitumumab as initial therapy for patients with unresectable RAS and BRAF wild-t...

by Borelli, Beatrice, Moretto, Roberto, Lonardi, Sara, Bonetti, Andrea, Antoniotti, Carlotta, Pietrantonio, Filippo, Masi, Gianluca, Burgio, Valentina, Marmorino, Federica, Salvatore, Lisa, Rossini, Daniele, Zaniboni, Alberto, Zucchelli, Gemma, Martignetti, Angelo, Di Battista, Monica, Pella, Nicoletta, Passardi, Alessandro, Boccaccino, Alessandra, Leone, Francesco, Colombo, Camilla, Granetto, Cristina, Vannini, Francesca, Marsico, Valentina Angela, Martinelli, Erika, Antonuzzo, Lorenzo, Vitello, Stefano, Delliponti, Laura, Boni, Luca, Cremolini, Chiara, Falcone, Alfredo
Published in ESMO Open (2018)